type here...

CATEGORIES

Breaking Research

LATEST

123Page 2 of 3

TRENDING

EDITORS CHOICE

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

James Coyne -
The largest number of authors (12) are with MAPS. The for-profit corporation will manage sales for prescription MDMA when it is approved by the FDA

The Remarkable Research Of CAR T Therapy: B Cell Cancers

William Haseltine, PhD -
The first installment lays the foundation for understanding how CAR T works. This second piece delves into the use of CAR T to treat B cell cancers.

A Pig Heart Was Transplanted Into a Human a Few Days Ago Is This The Future of Organ Transplantation?

Stephen Schimpff, MD MACP -
It is still a very experimental procedure, but it likely will be improved rapidly in the coming years and may become the standard approach...

How COVID and the Power of Now Killed Scientific Peer Review

Gil Bashe, Medika Life Editor -
How long do or should clinical trials take – well, it depends – but often years. Science takes time. It demands rigor and objectivity. It’s not a “now” pursuit.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories